These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10375045)

  • 1. Insulin resistance in obese hypertensive Asian Indian subjects.
    Marita AR; Desai A; Mokal R; Nair S; Dalal KP
    Int J Obes Relat Metab Disord; 1999 May; 23(5):445-8. PubMed ID: 10375045
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of fasting and post oral glucose serum insulin levels in hypertensive and obese subjects.
    Kothari K; Mathur A; Yadav S
    J Assoc Physicians India; 1998 Jun; 46(6):514-7. PubMed ID: 11273248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of insulin resistance to electrocardiographic changes in non obese Asian Indian subjects with hypertension.
    Marita AR; Desai A; Mokal R; Agarkar RY; Dalal KP
    Endocr Res; 1998 May; 24(2):215-33. PubMed ID: 9738699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure, insulin secretion and resistance in nonhypertensive and hypertensive obese female subjects.
    Sinagra D; Greco D; Scarpitta AM; Bonaventura V
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):610-3. PubMed ID: 8574270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leisure time physical activity and insulin resistance in young obese students with hypertension.
    Saito I; Nishino M; Kawabe H; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):915-8. PubMed ID: 1285941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and blood pressure levels are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. The Mauritius Non-communicable Disease Study Group.
    Dowse GK; Collins VR; Alberti KG; Zimmet PZ; Tuomilehto J; Chitson P; Gareeboo H
    J Hypertens; 1993 Mar; 11(3):297-307. PubMed ID: 8387088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects.
    Grandi AM; Gaudio G; Fachinetti A; Zanzi P; Bianchi L; Ceriani L; Guasti L; Venco A
    Eur J Clin Invest; 1997 Sep; 27(9):774-9. PubMed ID: 9352250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects.
    Bonora E; Moghetti P; Zenere M; Tosi F; Travia D; Muggeo M
    Int J Obes; 1990 Sep; 14(9):735-42. PubMed ID: 2228406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance and essential hypertension in Vietnamese subjects].
    Minh HV; Thanh LC; Ngoc PT; Trinh TD; Tho TD; Valensi P
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1143-5. PubMed ID: 9404424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and diastolic dysfunction in lean and obese hypertensives: genetic influence.
    Grandi AM; Zanzi P; Fachinetti A; Gaudio G; Ceriani L; Bertolini A; Guasti L; Venco A
    Hypertension; 1999 Dec; 34(6):1208-14. PubMed ID: 10601120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinaemia and slight overweight: the case of Vietnamese hypertensives.
    Van Minh H; Thanh LC; Thi BN; do Trinh T; Tho TD; Valensi P
    Int J Obes Relat Metab Disord; 1997 Oct; 21(10):897-902. PubMed ID: 9347408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension in obese patients with heart hypertrophy. Effects of captopril on insulin sensitivity and growth hormone].
    Velasco-Cornejo IF; Martin LC; Brandão-Neto J; Marchioli M; de Barros e Silva M; Anthanázio-Heliodoro Rde C; Franco RJ da S
    Arq Bras Cardiol; 1995 Feb; 64(2):125-32. PubMed ID: 7575157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance is a characteristic feature of primary hypertension independent of obesity.
    Pollare T; Lithell H; Berne C
    Metabolism; 1990 Feb; 39(2):167-74. PubMed ID: 2405235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.
    Maccario M; Oleandri SE; Avogadri E; Rossetto R; Grottoli S; Procopio M; Camanni F; Ghigo E
    J Endocrinol Invest; 1998 Jan; 21(1):56-63. PubMed ID: 9633024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic calcium and insulin resistance in elderly patients with essential hypertension.
    Byyny RL; LoVerde M; Lloyd S; Mitchell W; Draznin B
    Am J Hypertens; 1992 Jul; 5(7):459-64. PubMed ID: 1637518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study.
    Grassi G; Seravalle G; Dell'Oro R; Trevano FQ; Bombelli M; Scopelliti F; Facchini A; Mancia G;
    J Hypertens; 2003 Sep; 21(9):1761-9. PubMed ID: 12923410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and glucose metabolism in hypertensive middle-aged males.
    Berglund G; Larsson B; Andersson O; Larsson O; Svärdsudd K; Björntorp P; Wilhelmsen L
    Acta Med Scand; 1976; 200(3):163-9. PubMed ID: 970224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India.
    Snehalatha C; Sivasankari S; Satyavani K; Vijay V; Ramachandran A
    Diabet Med; 2000 Feb; 17(2):152-7. PubMed ID: 10746487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin, insulin sensitivity, and erythrocyte sodium metabolism in normotensive and essential hypertensive subjects with and without overweight.
    Sechi LA; Melis A; Pala A; Marigliano A; Sechi G; Tedde R
    Clin Exp Hypertens A; 1991; 13(2):261-76. PubMed ID: 2065466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.